Thrombolysisinmyocardialinfarction (TIMI) trial, Phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge - Chesebro, J; Knatterud, G; Roberts, R (Circulation, 1987)